Clinical implications of CYP2D6 genotyping on tamoxifen treatment in breast cancer
V.O. Dezentje, J.W.R. Nortier, H.J. Guchelaar, C.J.H. van de Velde, H. GelderblomVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70338-0
File:
PDF, 55 KB
english, 2008